Literature DB >> 11307043

Levodopa-induced drowsiness in healthy volunteers: results of a choice reaction time test combined with a subjective evaluation of sedation.

J Micallef-Roll1, P Rihet, T Hasbroucq, C Possamaï, O Blin.   

Abstract

The aim of the present study was to assess levodopa (L-Dopa)-induced drowsiness in healthy volunteers using two parameters: choice reaction time and a subjective rating of sedation. Sixteen subjects participated in a randomized, double-blinded, crossover study. A single dose of 200 mg L-Dopa or placebo was administered at 9:00 AM. To limit peripheral side effects connected with L-Dopa, subjects were treated with 20 mg domperidone three times daily. Subjective rating of sedation consisted of visual analogue scale. Reaction time was measured by means of responses to two light-emitting diodes. The illumination of one of these diodes constituted the imperative signal. Manual responses were performed on two buttons located under the right and left index fingers. Results demonstrated a positive correlation between sedation level and reaction time (r = 0.70, p = 0.0026). Adverse events of L-Dopa were nausea (four cases) and excitation (one case). Subjects who did not develop adverse events were faster under L-Dopa than under placebo (p = 0.02), whereas subjects who had nausea or excitation were slower. A single dose of L-Dopa either deteriorated or improved choice reaction time in healthy volunteers according to whether it was sedative and whether it generated disruptive adverse events.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11307043     DOI: 10.1097/00002826-200103000-00004

Source DB:  PubMed          Journal:  Clin Neuropharmacol        ISSN: 0362-5664            Impact factor:   1.592


  7 in total

1.  Brain T1 intensity changes after levodopa administration in healthy subjects: a voxel-based morphometry study.

Authors:  Pilar Salgado-Pineda; Pauline Delaveau; Carles Falcon; Olivier Blin
Journal:  Br J Clin Pharmacol       Date:  2006-06-23       Impact factor: 4.335

2.  Examination of the effect of acute levodopa administration on the loudness dependence of auditory evoked potentials (LDAEP) in humans.

Authors:  K Hitz; K Heekeren; C Obermann; T Huber; G Juckel; W Kawohl
Journal:  Psychopharmacology (Berl)       Date:  2011-11-26       Impact factor: 4.530

3.  Antiparkinsonian drug-induced sleepiness: a double-blind placebo-controlled study of L-dopa, bromocriptine and pramipexole in healthy subjects.

Authors:  Joëlle Micallef; Marc Rey; Alexandre Eusebio; Christine Audebert; Frank Rouby; Elisabeth Jouve; Sophie Tardieu; Oliver Blin
Journal:  Br J Clin Pharmacol       Date:  2008-09-19       Impact factor: 4.335

4.  Dopaminergic modulation of emotional memory in Parkinson's disease.

Authors:  Thomas D Hälbig; Ute A Kopp; Franziska Wodarz; Joan C Borod; Jean-Michel Gracies; Georg Ebersbach; Andreas Kupsch
Journal:  J Neural Transm (Vienna)       Date:  2008-05-28       Impact factor: 3.575

5.  Saccadic latency distributions in Parkinson's disease and the effects of L-dopa.

Authors:  A W Michell; Z Xu; D Fritz; S J G Lewis; T Foltynie; C H Williams-Gray; T W Robbins; R H S Carpenter; R A Barker
Journal:  Exp Brain Res       Date:  2006-03-17       Impact factor: 1.972

6.  Counterproductive effect of saccadic suppression during attention shifts.

Authors:  Alexandre Zénon; Brian D Corneil; Andrea Alamia; Nabil Filali-Sadouk; Etienne Olivier
Journal:  PLoS One       Date:  2014-01-23       Impact factor: 3.240

7.  Pramipexole Impairs Stimulus-Response Learning in Healthy Young Adults.

Authors:  Haley Gallant; Andrew Vo; Ken N Seergobin; Penny A MacDonald
Journal:  Front Neurosci       Date:  2016-08-19       Impact factor: 4.677

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.